You are here

cholesterol

Lilly's lipoprotein-blocking heart med posts midstage win, turning up heat on potential AZ showdown

Fierce Biotech

Tue, 11/19/24 - 11:16 am

clinical trials

Amgen, Family Heart Foundation launch at-home cholesterol screening for LDL-C Awareness Day

Medical Marketing and Media

Mon, 09/30/24 - 08:47 pm

Cholesterol Connect

Novartis builds case for Leqvio with monotherapy data

Pharmaphorum

Wed, 08/28/24 - 11:29 am

clinical trials

NewAmsterdam drug cuts cholesterol, but by less than expectations, in phase 3 test

Fierce Biotech

Mon, 07/29/24 - 10:27 am

NewAmsterdam Pharma

clinical trials

Statins for heart disease prevention could be recommended for far fewer Americans if new risk equation is adopted

Medical Xpress

Wed, 06/12/24 - 11:15 am

cardiovascular disease

AstraZeneca throws its hat into the oral PCSK9 ring

Pharmaphorum

Wed, 05/29/24 - 11:28 am

PCSK9 inhibitors

Esperion Targets Seven-Fold Jump in Cholesterol Drug Population with FDA Label Expansion

BioSpace

Mon, 03/25/24 - 11:19 am

Esperion Therapeutics

Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published

BioSpace

Thu, 02/15/24 - 11:40 am

Lilly’s Cholesterol Pill Shows Early Promise in Phase I Study

BioSpace

Tue, 08/29/23 - 11:15 am

clinical trials

Merck bets big on oral PCSK9 inhibitor, putting 6-year outcome study at heart of phase 3 program

Fierce Biotech

Fri, 08/25/23 - 09:57 am

PCSK9 inhibitors

clinical trials

cardiovascular disease

Cholesterol-focused Esperion loses appetite for oral PCSK9 collab with Serometrix

Fierce Biotech

Tue, 08/1/23 - 11:57 am

Esperion Therapeutics

PCSK9 inhibitors

ACC 2023 – Esperion’s outcomes win looks lacklustre

EP Vantage

Mon, 03/6/23 - 10:45 am

Esperion Therapeutics

Abionyx hails success of bid to resurrect failed cholesterol drug—without dishing data to back up claims

Fierce Biotech

Tue, 01/17/23 - 10:14 am

clinical trials

AstraZeneca dumps Ionis drug despite hit in phase 2 cholesterol trial

Fierce Biotech

Fri, 09/23/22 - 11:00 am

Ionis Pharmaceuticals

clinical trials

Drugmakers leap back into fading heart drug market

Beckers Hospital Review

Thu, 07/28/22 - 06:40 pm

Bristol Myers Squibb

Alnylam Pharmaceuticals

ACC 2022 – Astra’s cholesterol lowerer surprise comes just a little late

EP Vantage

Tue, 04/5/22 - 10:59 am

Ionis Pharmaceuticals

Can A New Cholesterol Drug Restore Merck’s Prominence In Heart Drugs?

Forbes

Tue, 02/1/22 - 10:48 am

PCSK9 inhibitors

Pfizer ends $3B drug dream despite phase 2b success, leaving Regeneron with a clear run at cardiovascular market

Fierce Biotech

Mon, 01/31/22 - 10:47 am

Ionis Pharmaceuticals

It Was To Be The Cholesterol Drug For The Masses. Novartis Changed That.

Forbes

Mon, 01/3/22 - 10:42 am

Novartis wins FDA approval for new heart drug, but faces uphill sales battle

BioPharma Dive

Wed, 12/22/21 - 11:35 pm

Pages